Table 10 Critical appraisal of quantitative studies reporting fatal and non-fatal overdose
No | Study | MMAT Section 3a for quantitative non-randomized studies | ||||
|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ||
Are the participants representative of the target population? | Are measurements appropriate regarding both the outcome and intervention (or exposure)? | Are there complete outcome data? | Are the confounders accounted for in the design and analysis?b | During the study period, is the intervention administered (or exposure occurred) as intended?b | ||
S2 | Aldabergenov et al., 2022 [70] | Yes | Yes | Yes | No | No |
S3 | Amram et al., 2021 [71] | No | Yes | Yes | Yes | Yes |
S6 | Corace et al., 2022 [74] | No | No | Yes | No | Yes |
S8 | Ezie et al., 2022 [76] | Yes | Can't tell | Yes | No | Can't tell |
S13 | Gomes et al., 2022 [81] | Yes | Yes | Yes | Yes | Yes |
S17 | Joseph et al., 2021 [85] | Can't tell | No | No | No | No |
S26 | Nguyen et al., 2021 [94] | No | Yes | Yes | No | No |
# meeting quality criteria | 3/7 | 4/7 | 6/7 | 2/7 | 3/7 | |